These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 21938600)

  • 1. "The promise of community-based advocacy and education efforts for increasing cancer clinical trials accrual".
    Michaels M; Weiss ES; Guidry JA; Blakeney N; Swords L; Gibbs B; Yeun S; Rytkonen B; Goodman R; Jarama SL; Greene AL; Patel S
    J Cancer Educ; 2012 Mar; 27(1):67-74. PubMed ID: 21938600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating a community-partnered cancer clinical trials pilot intervention with African American communities.
    Green MA; Michaels M; Blakeney N; Odulana AA; Isler MR; Richmond A; Long DG; Robinson WS; Taylor YJ; Corbie-Smith G
    J Cancer Educ; 2015 Mar; 30(1):158-66. PubMed ID: 25564207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of primary care provider knowledge, attitudes, and beliefs about cancer clinical trials: implications for referral, education and advocacy.
    Michaels M; D'Agostino TA; Blakeney N; Weiss ES; Binz-Scharf MC; Golant M; Bylund CL
    J Cancer Educ; 2015 Mar; 30(1):152-7. PubMed ID: 24805229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Five principles for effective cancer clinical trial education within the community setting.
    Michaels M; Blakeney N; Langford AT; Ford ME
    J Cancer Educ; 2015 Mar; 30(1):197-203. PubMed ID: 25005705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A community-academic partnership to explore informational needs of African American women as a primer for cancer clinical trial recruitment.
    Rivers DA; Pal T; Vadaparampil ST; Adams LA; Dash-Pitts L; Quinn GP
    Ethn Health; 2019 Aug; 24(6):679-693. PubMed ID: 28826243
    [No Abstract]   [Full Text] [Related]  

  • 6. The Impact of an Online Training Program About Cancer Clinical Trials on Primary Care Physicians' Knowledge, Attitudes and Beliefs, and Behavior.
    Bylund CL; Michaels M; Weiss ES; Patel S; D'Agostino TA; Binz-Scharf MC; McKee D
    J Cancer Educ; 2021 Oct; 36(5):1039-1044. PubMed ID: 32157570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perceptions of Cancer Care and Clinical Trials in the Black Community: Implications for Care Coordination Between Oncology and Primary Care Teams.
    Sprague Martinez L; Freeman ER; Winkfield KM
    Oncologist; 2017 Sep; 22(9):1094-1101. PubMed ID: 28706009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of medical oncologists' attitudes on accrual to clinical trials in a community setting.
    Somkin CP; Ackerson L; Husson G; Gomez V; Kolevska T; Goldstein D; Fehrenbacher L
    J Oncol Pract; 2013 Nov; 9(6):e275-83. PubMed ID: 24151327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of factors affecting awareness of and willingness to participate in cancer clinical trials.
    Lara PN; Paterniti DA; Chiechi C; Turrell C; Morain C; Horan N; Montell L; Gonzalez J; Davis S; Umutyan A; Martel CL; Gandara DR; Wun T; Beckett LA; Chen MS
    J Clin Oncol; 2005 Dec; 23(36):9282-9. PubMed ID: 16361626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Training Needs of Clinical and Research Professionals to Optimize Minority Recruitment and Retention in Cancer Clinical Trials.
    Niranjan SJ; Durant RW; Wenzel JA; Cook ED; Fouad MN; Vickers SM; Konety BR; Rutland SB; Simoni ZR; Martin MY
    J Cancer Educ; 2019 Feb; 34(1):26-34. PubMed ID: 28776305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementing a Memory Clinic Model to Facilitate Recruitment into Early Phase Clinical Trials for Mild Cognitive Impairment and Alzheimer's Disease.
    Park L; Kouhanim C; Lee S; Mendoza Z; Patrick K; Gertsik L; Aguilar C; Gullaba D; Semenova S; Jhee S
    J Prev Alzheimers Dis; 2019; 6(2):135-138. PubMed ID: 30756120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying locally actionable strategies to increase participant acceptability and feasibility to participate in Phase I cancer clinical trials.
    Staras SAS; Wollney EN; Emerson LE; Silver N; Dziegielewski PT; Hansen MD; Sanchez G; D'Ingeo D; Johnson-Mallard V; Renne R; Fredenburg K; Gutter M; Zamojski K; Vandeweerd C; Bylund CL
    Health Expect; 2024 Feb; 27(1):e13920. PubMed ID: 38041447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic review of barriers and facilitators to clinical trial enrollment among adolescents and young adults with cancer: Identifying opportunities for intervention.
    Siembida EJ; Loomans-Kropp HA; Trivedi N; O'Mara A; Sung L; Tami-Maury I; Freyer DR; Roth M
    Cancer; 2020 Mar; 126(5):949-957. PubMed ID: 31869454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enrolling Minority and Underserved Populations in Cancer Clinical Research.
    Wallington SF; Dash C; Sheppard VB; Goode TD; Oppong BA; Dodson EE; Hamilton RN; Adams-Campbell LL
    Am J Prev Med; 2016 Jan; 50(1):111-117. PubMed ID: 26470805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Research protocol for bridging research, accurate information and dialogue (BRAID)-clinical trials: a mixed-methods study of a community-based intervention to improve trust and diversify participation in clinical trials.
    Gutnick DN; Lozano P; Rodriguez Martinez S; Wang KW; Williams DA; Rapkin BD; Gonzalez-Lepage N
    Front Public Health; 2024; 12():1407726. PubMed ID: 39351035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing accrual in cancer clinical trials with a focus on minority enrollment: The William Beaumont Hospital Community Clinical Oncology Program Experience.
    Vicini F; Nancarrow-Tull J; Shah C; Chmielewski G; Fakhouri M; Sitarek SA; Feczko CT; Brzozowski C; Felten DL
    Cancer; 2011 Oct; 117(20):4764-71. PubMed ID: 21455995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing Racial and Ethnic Diversity in Cancer Clinical Trials: An American Society of Clinical Oncology and Association of Community Cancer Centers Joint Research Statement.
    Oyer RA; Hurley P; Boehmer L; Bruinooge SS; Levit K; Barrett N; Benson A; Bernick LA; Byatt L; Charlot M; Crews J; DeLeon K; Fashoyin-Aje L; Garrett-Mayer E; Gralow JR; Green S; Guerra CE; Hamroun L; Hardy CM; Hempstead B; Jeames S; Mann M; Matin K; McCaskill-Stevens W; Merrill J; Nowakowski GS; Patel MI; Pressman A; Ramirez AG; Segura J; Segarra-Vasquez B; Hanley Williams J; Williams JE; Winkfield KM; Yang ES; Zwicker V; Pierce LJ
    J Clin Oncol; 2022 Jul; 40(19):2163-2171. PubMed ID: 35588469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Collaborative development of clinical trials education programs for African-American community-based organizations.
    Blakeney N; Michaels M; Green M; Richmond A; Long D; Robinson WS; Spicer C; Elliott-Bynum S; Corbie-Smith G
    J Cancer Educ; 2015 Jun; 30(2):400-6. PubMed ID: 24906502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with biomedical research participation within community-based samples across 3 National Cancer Institute-designated cancer centers.
    Barrett NJ; Rodriguez EM; Iachan R; Hyslop T; Ingraham KL; Le GM; Martin K; Haring RC; Rivadeneira NA; Erwin DO; Fish LJ; Middleton D; Hiatt RA; Patierno SR; Sarkar U; Gage-Bouchard EA
    Cancer; 2020 Mar; 126(5):1077-1089. PubMed ID: 31909824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.